Return on Assets (ROA)
since 2012
Beginner level
Calculation
AbbVie Inc., ROA, long-term trends, calculation
| ROA | = | 100 | × | Net earnings1 | ÷ | Total assets1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | 8.84% | = | 100 | × | 7,882 | ÷ | 89,115 |
| Dec 31, 2018 | 9.58% | = | 100 | × | 5,687 | ÷ | 59,352 |
| Dec 31, 2017 | 7.50% | = | 100 | × | 5,309 | ÷ | 70,786 |
| Dec 31, 2016 | 9.01% | = | 100 | × | 5,953 | ÷ | 66,099 |
| Dec 31, 2015 | 9.70% | = | 100 | × | 5,144 | ÷ | 53,050 |
| Dec 31, 2014 | 6.44% | = | 100 | × | 1,774 | ÷ | 27,547 |
| Dec 31, 2013 | 14.14% | = | 100 | × | 4,128 | ÷ | 29,198 |
| Dec 31, 2012 | 19.53% | = | 100 | × | 5,275 | ÷ | 27,008 |
Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-03-15).
1 US$ in millions
Comparison to Competitors
AbbVie Inc., ROA, long-term trends, comparison to competitors
| AbbVie Inc. | Abbott Laboratories | Amgen Inc. | Biogen Inc. | Bristol-Myers Squibb Co. | Eli Lilly & Co. | Gilead Sciences Inc. | Illumina Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | Zoetis Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | 8.84% | 5.43% | 13.13% | 21.62% | 2.65% | 21.17% | 8.74% | 13.70% | 9.59% | 11.66% | 9.72% | 14.29% | 14.15% | 12.99% |
| Dec 31, 2018 | 9.58% | 3.53% | 12.64% | 17.52% | 14.06% | 7.36% | 8.57% | 11.87% | 10.00% | 7.53% | 7.00% | 20.83% | 33.57% | 13.25% |
| Dec 31, 2017 | 7.50% | 0.63% | 2.48% | 10.73% | 3.00% | -0.45% | 6.58% | 13.81% | 0.83% | 2.72% | 12.40% | 13.67% | 7.43% | 10.06% |
| Dec 31, 2016 | 9.01% | 2.66% | 9.95% | 16.19% | 13.22% | 7.05% | 23.70% | 10.81% | 11.71% | 4.11% | 4.20% | 12.84% | -3.87% | 10.73% |
| Dec 31, 2015 | 9.70% | 10.72% | 9.69% | 18.19% | 4.93% | 6.77% | 34.93% | 12.52% | 11.55% | 4.36% | 4.16% | 11.34% | -22.26% | 4.28% |
| Dec 31, 2014 | 6.44% | 5.53% | 7.47% | 20.50% | 5.94% | 6.43% | 34.91% | 10.58% | 12.45% | 12.12% | 5.40% | 8.99% | -31.63% | 8.82% |
| Dec 31, 2013 | 14.14% | 6.00% | 7.68% | 15.70% | 6.64% | 13.29% | 13.67% | 4.15% | 10.42% | 4.17% | 12.78% | 14.38% | -19.19% | 7.69% |
| Dec 31, 2012 | 19.53% | 8.87% | 8.00% | 13.62% | 5.46% | 11.89% | 12.20% | 5.89% | 8.94% | 5.81% | 7.84% | 36.06% | -3.88% | 6.96% |
Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-03-15).
Comparison to Sector (Pharmaceuticals & Biotechnology)
AbbVie Inc., ROA, long-term trends, comparison to sector (pharmaceuticals & biotechnology)
| AbbVie Inc. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2019 | 8.84% | 9.66% |
| Dec 31, 2018 | 9.58% | 9.34% |
| Dec 31, 2017 | 7.50% | 5.20% |
| Dec 31, 2016 | 9.01% | 8.89% |
| Dec 31, 2015 | 9.70% | 9.61% |
| Dec 31, 2014 | 6.44% | 9.90% |
| Dec 31, 2013 | 14.14% | 9.65% |
| Dec 31, 2012 | 19.53% | 8.63% |
Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-03-15).
Comparison to Industry (Health Care)
AbbVie Inc., ROA, long-term trends, comparison to industry (health care)
| AbbVie Inc. | Health Care | |
|---|---|---|
| Dec 31, 2019 | 8.84% | 8.66% |
| Dec 31, 2018 | 9.58% | 8.11% |
| Dec 31, 2017 | 7.50% | 5.20% |
| Dec 31, 2016 | 9.01% | 7.57% |
| Dec 31, 2015 | 9.70% | 7.83% |
| Dec 31, 2014 | 6.44% | 8.81% |
| Dec 31, 2013 | 14.14% | 8.94% |
| Dec 31, 2012 | 19.53% | 7.82% |
Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-03-15).